Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (40)	1/1/2000 1:14:00 PM
From: scaram(o)uche	of 1833

from the new OSIP 10-K...... GPCR DIRECTED OSI OWNED: (ADENOSINE RECEPTORS): - 1 target in IND track - Heart Disease - 3 targets in Lead Optimization - Asthma/Inflammation - Glaucoma OSI/SOLVAY FUNDED COLLABORATION WITH MILESTONES & ROYALTIES: - Parkinson's Disease - 1 target in IND track (licensed to Solvay with milestones & royalties) - multiple targets in Lead Seeking

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next